{"central venous catheterisation": 137.85, "condition aggravated": 4.87, "device related infection": 25.3, "drug ineffective": 3.83, "drug ineffective for unapproved indication": 27.31, "hereditary angioedema": 308.67, "illness": 2.16, "infection": 2.42, "intentional product use issue": 75.87, "kidney infection": 15.0, "laryngeal oedema": 12.51, "maternal exposure during breast feeding": 12.64, "maternal exposure during pregcy": 11.54, "nephrolithiasis": 8.33, "pharyngeal swelling": 109.84, "pneumonia": 2.83, "product dose omission issue": 5.27, "product use in unapproved indication": 9.86, "respiratory tract oedema": 210.82, "sepsis": 5.24, "sinusitis": 6.46, "therapeutic product effect incomplete": 20.46, "thrombosis": 5.27, "underdose": 17.28, "vascular access complication": 934.29, "vascular access site complication": 8914.86, "vascular device infection": 38.85}